Commonwealth Numbered Regulations

1983 No. 23 COMMONWEALTH SERUM LABORATORIES REGULATIONS (AMENDMENT) - REG 2

2. The Commonwealth Serum Laboratories Regulations are amended by adding at
the end thereof the following regulation: Prescribed pharmaceutical products

"4. The following pharmaceutical products (in any form) are prescribed for the
purposes of paragraph 19 (1) (a) of the Commonwealth Serum Laboratories  Act
1961 :
    (a)    amiloride hydrochloride;

    (b)    amitriptyline embonate;

    (c)    amitriptyline hydrochloride;

    (d)    benztropine mesylate;

    (e)    chlorothiazide;

    (f)    cyproheptadine hydrochloride;

    (g)    diflunisal;

    (h)    ethacrynic acid;

    (i)    mixtures of hydrochlorothiazide and amiloride hydrochloride;

    (j)    hydrochlorothiazide;

    (k)    indomethacin;

    (l)    mixtures of levodopa and carbidopa;

    (m)    mecamylamine hydrochloride;

    (n)    methyldopa;

    (o)    prpbenecid;

    (p)    protriptyline hydrochloride;

    (q)    pyrazinamide;

    (r)    sulindac;

    (s)    thiabendazole;     (t)    timolol maleate;     (u)    mixtures of
Vitamin B complex with glycerophosphates.".